Reviva Pharmaceuticals Holdings, Inc. (RVPH)

RVPH Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10.36	13.48	23.37	18.52	29.69	8.76
Cash & Short-Term Investments	10.36	13.48	23.37	18.52	29.69	8.76
Cash Growth	67.75%	-42.33%	26.17%	-37.62%	238.89%	4538999.48%
Prepaid Expenses	0.45	1.21	0.33	0.4	1.72	0
Total Current Assets	10.82	14.68	23.7	18.92	31.4	8.76
Other Long-Term Assets	0.82	0.82	-	-	-	-
Total Assets	11.63	15.5	23.7	18.92	31.4	8.76
Accounts Payable	4.97	6.28	3.85	3.52	0.51	1.01
Accrued Expenses	6.07	7.36	12.93	6.14	1.84	0.32
Short-Term Debt	0.11	0.46	-	-	-	-
Other Current Liabilities	0.92	0.5	0.4	0.3	-	-
Total Current Liabilities	12.08	14.6	17.18	9.96	2.34	1.33
Other Long-Term Liabilities	0.02	0.09	0.81	0.57	0.37	1.96
Total Liabilities	12.09	14.69	17.98	10.53	2.72	3.3
Common Stock	0.01	0	0	0	0	0
Additional Paid-In Capital	176.29	165.08	140.07	103.49	95.52	63.77
Retained Earnings	-176.76	-164.27	-134.35	-95.09	-66.83	-58.31
Total Common Equity	-0.46	0.81	5.72	8.39	28.69	5.47
Shareholders' Equity	-0.46	0.81	5.72	8.39	28.69	5.47
Total Liabilities & Equity	11.63	15.5	23.7	18.92	31.4	8.76
Total Debt	0.11	0.46	-	-	-	-
Net Cash (Debt)	10.25	13.02	23.37	18.52	29.69	8.76
Net Cash Growth	71.68%	-44.29%	26.17%	-37.62%	238.89%	-
Net Cash Per Share	0.24	0.39	0.98	0.95	2.01	2.86
Filing Date Shares Outstanding	68	46.74	27.92	20.45	15.13	9.23
Total Common Shares Outstanding	68	46.58	27.92	20.45	14.43	9.23
Working Capital	-1.26	0.08	6.53	8.96	29.06	7.43
Book Value Per Share	-0.01	0.02	0.20	0.41	1.99	0.59
Tangible Book Value	-0.46	0.81	5.72	8.39	28.69	5.47
Tangible Book Value Per Share	-0.01	0.02	0.20	0.41	1.99	0.59

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q